Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
주식 순위 #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
주가
$59.98
마지막 동기화: 2024-12-13
시가총액
$1.22B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Longboard Pharmaceuticals, Inc. (LBPH)

카테고리

Longboard Pharmaceuticals, Inc. (LBPH)의 P/S 비율
August 2026 기준 P/S 비율 TTM: 0.00
Longboard Pharmaceuticals, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0.00입니다. 2022년 말 기준 P/S 비율은 0.00였습니다.
Longboard Pharmaceuticals, Inc.의 P/S 비율 기록 (2020 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
2026 (TTM) 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
10.17 -
US
10.13 -
NL
2.95 -
AU
11.28 -
US
- -
CH